Stock Scorer

Gossamer Bio, Inc. (GOSS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 35M 70M 105M Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 95.8M Q3 '24: 9.5M Q4 '24: 9.4M Q1 '25: 9.9M Q2 '25: 11.5M Q3 '25: 13.3M Q4 '25: 13.8M Q1 '26: 17M Q2 '26: 9.2M Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '21: -55.7M Q4 '21: -51.7M Q1 '22: -54.3M Q2 '22: -53.9M Q3 '22: -56M Q4 '22: -54.4M Q1 '23: -47.9M Q2 '23: -46.3M Q3 '23: -40.5M Q4 '23: -49M Q1 '24: -42M Q2 '24: 52.1M Q3 '24: -33.9M Q4 '24: -36.1M Q1 '25: -36.8M Q2 '25: -38.8M Q3 '25: -49.1M Q4 '25: -46M Q1 '26: -44.9M Q2 '26: -26.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -60.2M Q4 '21: -56.3M Q1 '22: -57.8M Q2 '22: -56.5M Q3 '22: -59.4M Q4 '22: -55.8M Q1 '23: -49.2M Q2 '23: -42.5M Q3 '23: -40M Q4 '23: -48.1M Q1 '24: -41.9M Q2 '24: 49.2M Q3 '24: -30.8M Q4 '24: -33M Q1 '25: -36.6M Q2 '25: -38.3M Q3 '25: -48.2M Q4 '25: -47.2M Q1 '26: -46.7M Q2 '26: 16.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-80M -40M 0 40M 80M 120M Q3 '21: -42M Q4 '21: -40.5M Q1 '22: -53.5M Q2 '22: -48.8M Q3 '22: -37M Q4 '22: -47.7M Q1 '23: -53M Q2 '23: -38.3M Q3 '23: -34.5M Q4 '23: -33.4M Q1 '24: -52.3M Q2 '24: 116.3M Q3 '24: -32M Q4 '24: -35.5M Q1 '25: -39.7M Q2 '25: -47.1M Q3 '25: -36.2M Q4 '25: -48.3M Q1 '26: -38.7M Q2 '26: -39.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-80M -40M 0 40M 80M 120M Q3 '21: -42.6M Q4 '21: -40.6M Q1 '22: -53.6M Q2 '22: -48.9M Q3 '22: -37M Q4 '22: -47.8M Q1 '23: -53M Q2 '23: -38.3M Q3 '23: -34.5M Q4 '23: -33.4M Q1 '24: -52.3M Q2 '24: 116.3M Q3 '24: -32M Q4 '24: -35.5M Q1 '25: -39.8M Q2 '25: -47.1M Q3 '25: -36.2M Q4 '25: -48.3M Q1 '26: -38.7M Q2 '26: -39.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '20: 61.9M Q2 '20: 66.6M Q3 '20: 72.2M Q1 '21: 74.1M Q2 '21: 74.7M Q3 '21: 75M Q1 '22: 75.9M Q2 '22: 76.7M Q3 '22: 91.2M Q1 '23: 94.9M Q2 '23: 95.4M Q3 '23: 192.9M Q1 '24: 225.7M Q2 '24: 238.5M Q3 '24: 226.3M Q1 '25: 226.8M Q2 '25: 227.3M Q3 '25: 228M Q1 '26: 234.1M Q2 '26: 328.8M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '21: -3.26 Q4 '21: -3.13 Q1 '22: -3.11 Q2 '22: -3.05 Q3 '22: -2.90 Q4 '22: -2.72 Q1 '23: -2.48 Q2 '23: -2.19 Q3 '23: -1.75 Q4 '23: -1.33 Q1 '24: -1.00 Q2 '24: -0.33 Q3 '24: -0.26 Q4 '24: -0.26 Q1 '25: -0.23 Q2 '25: -0.62 Q3 '25: -0.69 Q4 '25: -0.75 Q1 '26: -0.79 Q2 '26: -0.70 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for GOSS: Gross Profit, Cost of Revenue. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.